PDE inhibitors are now studied for their use in several pathologies such pulmonary disease (COPD, asthma), sexual dysfunction, vascular disease, neurogenerative disease, depression, diabetes, rheumatoid arthritis and cancer [22]. Here, ALDH7A1 is linked to asthma.